Epidemiology of Hepatitis E
Emerging Disease Notice
December 2003
Summary
Researchers have hypothesized that hepatitis E (HEV) is a
zoonotic disease, but direct evidence to support this claim
has been lacking. New information documenting
the zoonotic transmission of HEV was reported in
2003 from
A fact sheet about hepatitis E virus is available from the
National Pork Board (Halbur 2001b, www.porkscience.org/documents/Other/hepatitisevirusfacsheet.pdf
). Recent reviews of hepatitis E virus
include a summary of HEV seroepidemiology, molecular
biology and vaccine development (Emerson 2003) and a comprehensive review
by Meng (2003). A substantial
amount of new information has been learned about hepatitis E since its discovery
in the
Epidemiology of Hepatitis E
Hepatitis E virus (HEV) is the major etiologic agent of enterically transmitted non-A, non-B hepatitis in humans worldwide, and is a spherical, non-enveloped, single stranded RNA virus (Emerson 2003). HEV was formerly classified as a calicivirus, but has been reassigned as unclassified.
Until 1997, hepatitis E was thought to occur only in developing
countries including Africa, central Asian republics of the former Soviet Union,
Since 1997, HEV has been documented in humans and swine in
many countries previously considered nonendemic,
including Argentina, Australia, Austria, Canada, Germany, Greece, Japan, Korea,
the Netherlands, New Zealand, Spain, and Taiwan (Chandler 1999, Pina
2000, Schlauder 2000, Worm 2000, Garkavenko
2001, Purcell 2001, van der Poel
2001, Yoo 2001, Pei 2002,
Meng 2003, Takahashi 2003, Teich
2003, Widdowson 2003). Based on nucleotide and protein sequencing of
HEV isolates, 4 major genotypes have been described worldwide (Meng 2003, Emerson 2003).
Genotype 1 includes Asian and African strains, genotype 2 includes
a single Mexican strain, genotype 3 includes
Epidemiology in swine
HEV is ubiquitous in swine in the
Seroprevalence varies by age in swine herds. As reported in an article authored by Meng (1997), IgG anti-HEV antibodies were not detected in most pigs less than 2 months of age, but were found in 100.0 percent of swine aged 2-8 months, and in 85.4 percent of adult swine. Not all piglets are born seronegative; in a prospective study of a naturally infected commercial herd, only strongly seropositive sows passively transferred IgG anti-HEV antibodies to their piglets; however, antibodies waned by 8-9 weeks of age, at which point most piglets developed HEV infection and developed their own anti-HEV antibodies. Seronegative or only weakly seropositive sows had piglets that were seronegative. It is possible for swine herds to be free of HEV. In the seroprevalence study described above, a 16th herd that was specific pathogen free (SPF) was negative for anti-HEV antibodies (Meng 1997).
Transmission of HEV among swine appears to occur through
a fecal-oral route of exposure at approximately 1-3 months of age, with a
majority of animals exposed by 6-8 months of age (Meng
1997, Wu 2002, Takahashi 2003). In
Epidemiology in other animal species
Antibodies to HEV are prevalent in wild and domestic rodents
in the
Avian HEV is genetically related to but distinct from human
and swine HEVs (Huang 2002b). Avian HEV appears to be prevalent in the
Hepatitis E in Humans
Multiple serologic studies indicate that human infection
with HEV is relatively common. The
incidence of clinically apparent disease in humans in the
Risk Factors for Human Exposure to HEV
Hepatitis E is a zoonotic disease
but risk factors for disease transmission to humans are largely unknown (Halbur 2003, Meng 2003). Exposure to swine or wild animals appears to
be associated with the development of anti-HEV antibodies in humans, although
seroconversion has been documented in individuals with no
history of these exposures, indicating other sources of infection (Drobeniuc 2001, Halbur 2001, Meng 2002, Mizuno 2002, Meng 2003). Unfortunately,
detection of anti-HEV antibodies through serologic testing provides no information
about the HEV strain source; therefore, serology is of limited usefulness
in identifying risk factors for disease transmission. New information from
In a study of 11 Japanese patients with hepatitis retrospectively diagnosed as hepatitis E, several patients reported no history of exposure to swine or rodents, two had occupational exposure to raw beef, pork and chicken meat and one patient was a swine farmer (Mizuo 2002). Huang (2002) raised the concern that swine fecal contamination of irrigation or coastal waters could contaminate produce or fish harvested for human consumption; however, HEV was not isolated from surface water adjacent to commercial swine facilities (Halbur 2003). Emerson (2003) has hypothesized that rodents would be a likely reservoir for HEV, given their wide distribution across a variety of human habitats. Additional studies are needed to identify the sources and risk factors for human exposure to HEV.
Clinical Illness in Animals
Hepatitis E virus infection does not cause clinical illness
in swine. Experimental exposure of
2- to 4-week-old swine with human and swine HEV found no evidence of clinical
disease or elevation of liver enzymes (Halbur 2001,
Williams 2001). All infected swine
developed anti-HEV antibodies; most within 27 days postinoculation. Experimentally inoculated swine did develop
mild hepatic lesions consisting of enlarged hepatic and mesenteric lymph nodes,
multifocal lymphoplasmacytic hepatitis
and hepatocellular necrosis. Swine infected with the human HEV strain had
more severe lesions than swine infected with the
Pathogenesis in Swine
In 2- to 4-week-old swine intravenously inoculated with a
U.S. swine strain of HEV, viral RNA was detected in a variety of tissues between
day 3 to 27 post-inoculation (Williams 2001). Positive tissues included liver, lymph nodes,
colon, small intestines, stomachs, spleens, kidneys, tonsils, salivary glands,
and lungs. Virus was not detected in
blood after day 14 post-inoculation and was not detected in any tissue by
day 55 post-inoculation. Similar results
were found in a second group of swine inoculated with a
Prevention
Until more is known about the animal reservoirs and modes of transmission of HEV among swine and other animal species, and how HEV is transmitted to humans, it will be difficult to determine what, if any, preventive measures should be recommended in the U.S and other developed countries. In developing countries, prevention of HEV relies primarily on the provision of clean water supplies and overall improved sanitation and hygiene. Vaccines currently under development may provide a means of prevention in the future.
For questions or comments about this document, please contact
Kathy Orloski at (970) 494-7221 or kathy.a.orloski@aphis.usda.gov.
References
1.
Centers for Disease Control and Prevention.
Hepatitis E among
2. Chandler JD, Riddell MA, Li F, et al. Serological evidence for swine hepatitis E virus infection in Australian pig herds. Vet Microbiol 1999;68(1-2):95-105.
3. Chin J, ed. Viral hepatitis E. In: Control of Communicable Diseases Manual. Washington, D.C.: APHA; 2000. p. 255-7.
4.
Choi IS, Kown HJ, Shin NR, Yoo HS. Identification
of swine hepatitis E virus (HEV) and prevalence of anti-HEV antibodies in
swine and human populations in
5. Clemente-Casares P, Pina S, Buti M, et al. Hepatitis E virus epidemiology in industrialized countries. Emerg Infect Dis 2003;9(4):448-454.
6. Dawson GJ, Chau KH, Cabal CM, et al. Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J Virol Methods 1992;38(1):175-86.
7. Drobeniuc J, Favorov MO, Shapiro CN, et al. Hepatitis E virus antibody prevalence among persons who work with swine. J Infect Dis 2001;184:1594-7.
8. Emerson SU, Purcell RH. Hepatitis E virus. Rev Med Virol 2003;13:145-154.
9.
Favorov MO, Kosoy MY, Tsarev
SA, et al.
Prevalence of antibody to hepatitis E virus among rodents in the
10. Garkavenko O, Obriadina A, Ming
J, et al. Detection and characterization of swine hepatitis
E virus in
11. Halbur PG, Kasorndorkbua C, Gilbert C, et al. Comparative pathogenesis of infection of pigs with hepatitis E viruses recovered from a pig and a human. J Clin Microbiol 2001;39(3):918-23.
12. Halbur PG, Kasorndorkbua C, Meng XJ. Swine health fact sheet. 2001b online publication. www.porkscience.org/documents/Other/hepatitisevirusfacsheet.pdf, accessed October 23, 2003.
13. Halbur P, Kasorndorkbua C, Meng XJ. Hepatitis E Virus: Zoonotic threat or harmless commensal of pigs? Eleventh Annual Swine Disease Conference for Swine Practitioners, November 6-7, 2003, Iowa State University, Ames.
14. Hsieh SY, Meng XJ,
Wu YH, et al. Identify of a novel swine hepatitis E virus
in
15. Huang FF, Haqshenas G, Guenette DK, et al.
Detection by reverse transcription-PCR and genetic characterization
of field isolates of swind hepatitis E virus from
pigs in different geographic regions of the
16. Huang FF, Haqshenas G, Shivaprasad HL, et al.
Heterogeneity and seroprevalence of a newly
identified avian hepatitis E virus from chickens in the
17. Kabrane-Lazizi Y, Fine JB, Glass GE, et al. Evidence for widespread
infection of wild rats with hepatitis E virus in the
18. Kasorndorkbua C, Thacker BJ, Halbur PG, et al. Experimental infection of pregnant gilts with swine hepatitis E virus. Can J Vet Res 2003;67(4):303-6.
19. Karetnyi YV, Gilchrist MJ, Naides SJ. Hepatitis E virus infection prevalence among selected populations in Iowa. J Clin Virol 1999;14(1):51-5.
20. Kuno A, Ido K, Isoda N, et al. Sporadic acute hepatitis E of a 47-year-old man whose pet cat was positive for antibody to hepatitis E virus. Hep Research 2003;26:237-242.
21. Kwo PY, Schlauder GG, Carpenter
HA, et al. Acute hepatitis E by a new isolate acquired
in the
22. Matsuda H, Okada K, Takahashi K, Mishiro S. Severe hepatitis E virus infection after ingestion of uncooked liver from a wild boar. J Infect Dis 2003;188:944.
23. Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus. Proc Natl Acad Sci 1997;94:9860-9865.
24. Meng XJ, Dea S, Engle RE, et al. Prevalence of antibodies to the hepatitis E virus in pigs from countries where hepatitis E is common or is rare in the human population. J Med Virol 1999;59:297-302.
25. Meng XJ. Novel strains of hepatitis E virus identified from humans and other animal species: Is hepatitis E a zoonosis? J Hepatol 2000;33:842-45.
26. Meng XJ, Wiseman B, Elvinger F,
et al.
Prevalence of antibodies to hepatitis E in veterinarians working with
swine and in normal blood donors in the
27. Meng XJ. Swine hepatitis E virus: cross-species infection and risk in xenotransplantation. Curr Top Microbiol Immunol 2003;278:185-215.
28. Mizuo H, Suzuki K, Takikawa Y, et al.
Polyphyletic strains of hepatitis E virus are responsible for sporadic
cases of acute hepatitis in
29. Nishizawa T, Takahashi M, Mizuo H, et al. Characterization of Japanese swine and human hepatitis E virus isolates of genotype IV with 99% identity over the entire genome. J Gen Virol 2003;84:1245-51.
30. Pei Y, Yoo D. Genetic characterization and sequence heterogeneity of a Canadian isolate of swine hepatitis E virus. J Clin Microbiol 2002;40(11):4021-29.
31. Pina S, Buti M, Cotrina M, et al. HEV identified in serum from humans with acute
hepatitis and in sewage of animal origin in
32. Purcell RH, Emerson SU. Animal models of hepatitis A and E. ILAR Journal 2001;42(2):161-77.
33. Redlinger T, O’Rourke K, Nickey L, Martinez G. Elevated hepatitis A and E seroprevalence rates in a Texas/Mexico border community. Tex Med 1998;94(5):68-71.
34. Schlauder GG, Dawson GJ, Erker JC,
et al. The sequence and phylogenetic
analysis of a novel hepatitis E virus isolated from a patient with acute hepatitis
reported in the
35. Schlauder GG, Frider B, Sookoian S, et al. Identification of 2 novel isolates of hepatitis
E in
36. Smith HM, Reporter R, Rood MP, et al. Prevalence study of antibody to ratborne pathogens and other agents among patients using a free clinic in downtown Los Angeles. J Infect Dis 2002;186:1673-6.
37. Takahashi M, Nishizawa
T, Miyajima H, et
al. Swine hepatitis E virus strains in
38. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003;362:371-73.
39. Teich N, Tannapfel A, Ammon A, et al. Sporadic acute hepatitis e in
40. Thomas DL, Yarbough PO, Vlahov D, et al. Seroreactivity to hepatitis E virus in areas where the disease is not endemic. J Clin Microbiol 1997;35(5):1244-7.
41. Tsang THF, Denison EK, Williams HV, et al. Acute hepatitis E infection acquired in California. Clin Infect Dis 2000;30:618-9.
42. van der Poel WHM, Verschoor F, van der Heide R, et al.
Hepatitis E virus sequences in swine related to sequences in humans,
the
43. Widdowson MA, Jaspers WJM, van der Poel WHM, et al. Cluster of cases of acute hepatitis associated with hepatitis E virus infection acquired in The Netherlands. Clin Infect Dis 2003;36:29-33.
44. Williams TPE, Kasorndorkbua C, Halbur PG, et al. Evidence of extrahepatic sites of replication of the hepatitis E virus in a swine model. J Clin Microbiol 2001;39(9):3040-46.
45. Worm HC, Schlauder GG, Wurzer H, Mushahwar IK. Identification
of a novel variant of hepatitis E virus in
46. Wu JC, Chen CM, Chiang
TY, et al. Spread of hepatitis E virus among different-aged
pigs: Two-year survey in
47. Yazaki Y, Mizuo H, Takahashi M, et
al. Sporadic acute or fulminant hepatitis E Hokkaido,
48. Yoo D, Willson P, Pei Y, et al. Prevalence of hepatitis E virus antibodies in Canadian swine herds and identification of a novel variant of swine hepatitis E virus. Clin Diag Lab Immunol 2001;8(6):1213-19.